Clinica Baviera (ES:CBAV) has released an update.
Clinica Baviera has announced an Extraordinary General Meeting (EGM) to be held on November 6, 2024, with a second call on the following day if needed. The agenda includes the appointment of a director and the delegation of powers for agreement formalization and registration. Shareholders eligible to attend are those holding at least 50 shares, with the documentation available on the company’s website.
For further insights into ES:CBAV stock, check out TipRanks’ Stock Analysis page.
